1-PROPANOL AND 1-PROPYLAMINE DERIVATIVES AND THEIR USE AS GLUCOCORTICOID LIGANDS

Details for Australian Patent Application No. 2003297471 (hide)

Owner BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Inventors Hammach, Abdelhakim; Kuzmich, Daniel; Thomson, David S.; Proudfoot, John Robert; Bekkali, Younes; Kirrante, Jr. Thomas Martin; Ralph, Mark Stephen; Zindell, Renee; Lee, Thomas Wai-Ho; Regan, John Robinson

Agent Davies Collison Cave

Pub. Number AU-A-2003297471

PCT Number PCT/US2003/0409

PCT Pub. Number WO2004/063163

Priority 60/437,925 03.01.03 US; 60/445,192 05.02.03 US

Filing date 18 December 2003

Wipo publication date 10 August 2004

International Classifications

C07D 215/22 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 031/47 - Quinolines

C07D 295/18 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/08 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 265/36 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 215/42 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 241/38 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 241/42 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 241/44 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 279/12 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

C07D 279/16 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

C07D 239/88 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 237/28 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 231/56 Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 213/64 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 209/34 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/48 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 265/22 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 243/08 Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 213/69 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 243/14 Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 215/06 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 211/46 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/62 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 239/90 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 213/85 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 211/74 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 239/42 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 213/68 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/74 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 207/14 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 217/04 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 307/24 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 241/08 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 209/44 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 307/68 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 295/10 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 209/08 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 295/20 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 211/60 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 295/14 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 317/58 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

6 May 2004 Complete Application Filed

Priority application(s): 60/437,925 03.01.03 US; 60/445,192 05.02.03 US

9 September 2004 Application Open to Public Inspection

Published as AU-A-2003297471

16 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.